Tus kws kho mob
QP51-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 15, 2024
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 26, 2024
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1141 - 1150 ntawm 3685
Tus kws kho mob
QP50-24 Training Webinars for New Medical Drug Vendor, MagellanRx Management
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 26, 2024
Tus kws kho mob
P40-24 MCG Care Guidelines 28th Edition
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 03, 2024
Tus kws kho mob
P38-24 eviCore Healthcare Specialty Utilization Management (UM) Program: Cardiology and Radiology Clinical Guideline Updates
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 03, 2024
Tus kws kho mob
P42-24 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 03, 2024
Tus kws kho mob
QP38-24 Training Webinars for New Prior Authorization Submission Process
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 22, 2024
Tus kws kho mob
QP37-24 Update for New-to-Market Medical Drugs: atidarsagene autotemcel, crovalimab, and fidanacogene eleparvovec
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 08, 2024
Tus kws kho mob
P41-24 Change to Management of Medical Specialty Drugs
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 03, 2024
Tus kws kho mob
P39-24 New and Updated Reimbursement Policies, Effective August 5, 2024
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 03, 2024